2013
DOI: 10.1007/s11307-013-0668-1
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers

Abstract: The rapid one-step radiolabeling strategy by the complexation of (18)F-aluminum fluoride with NOTA-peptide conjugates was successfully applied to synthesize three dimeric RGD peptides. Among the three probes developed, (18)F-AlF-NOTA-E[PEG4-c(RGDfk)]2 with relatively low liver uptake and high tumor accumulation appears to be a promising candidate for further translational research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
72
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 41 publications
(74 citation statements)
references
References 35 publications
2
72
0
Order By: Relevance
“…Labeled by 18 F, 68 Ga, or 99m Tc, several RGD-based PET or SPECT tracers have been investigated in a series of landmark clinical trials (15,22,(24)(25)(26)(27)(28)(29). Recently, 18 F-NOTA-PRGD2 (denoted as alfatide) has shown to be promising in imaging properties and pharmacokinetics in preclinical or clinical studies (17)(18)(19). Further research in 18 F-Alfatide II (an upgraded version of alfatide) demonstrates great potential of this new tracer in detecting malignant bone and brain metastases (30,31).…”
Section: Immunohistochemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…Labeled by 18 F, 68 Ga, or 99m Tc, several RGD-based PET or SPECT tracers have been investigated in a series of landmark clinical trials (15,22,(24)(25)(26)(27)(28)(29). Recently, 18 F-NOTA-PRGD2 (denoted as alfatide) has shown to be promising in imaging properties and pharmacokinetics in preclinical or clinical studies (17)(18)(19). Further research in 18 F-Alfatide II (an upgraded version of alfatide) demonstrates great potential of this new tracer in detecting malignant bone and brain metastases (30,31).…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…Alfatide II [NOTA-E[PEG 4 -c(RGDfk)] 2 , an upgraded version of dimer RGD (Arg-Gly-Asp)-based tracer targeting the neovascular marker integrin a v b 3 , has been proven to be of lower liver uptake and higher tumor accumulation in mice (17). Clinical data are required to understand whether this new RGD-based angiogenesis tracer can highlight NSCLC lesions as well as differentiate lung TB from NSCLC.…”
mentioning
confidence: 99%
“…The synthesis of the 18 F-alfatide II was based on the technique described in previous published papers (Guo et al, 2014;Kiesewetter et al, 2012). After comparison of three dimeric 18 F-AlF-NOTA-RGD Tracers (Guo et al, 2014), we used NOTA-PEG 4 -E[c(RGDfk) 2 ] as precursor.…”
Section: Radiopharmaceutical Preparationmentioning
confidence: 99%
“…The synthesis of the 18 F-alfatide II was based on the technique described in previous published papers (Guo et al, 2014;Kiesewetter et al, 2012). After comparison of three dimeric 18 F-AlF-NOTA-RGD Tracers (Guo et al, 2014), we used NOTA-PEG 4 -E[c(RGDfk) 2 ] as precursor. The radiochemical purity of the 18 F-alfatide II syntheses was above 98%, assessed by an analytical high performance liquid chromatography system equipped with an ultraviolet and radioactivity detector, and the radiochemical yield was more than 40% (decay corrected), with specific activity of 21 MBq/mmol.…”
Section: Radiopharmaceutical Preparationmentioning
confidence: 99%
See 1 more Smart Citation